HSP90AB1 and neoplasm: Herein, we applied AUY922, a well‐known N‐terminal HSP90 inhibitor (with IC50 values of 7.8 and 21 nM for HSP90α and HSP90β) for its anti‐tumor property in IMQ‐induced psoriasis mouse model.